World Theranostics Day: What It Means for the Future of Cancer Care
Each year on March 31, the global medical community recognizes World Theranostics Day, a milestone moment that highlights one of the most exciting advances in modern medicine: theranostics.
At CB Oncology, we are proud to join this global movement by raising awareness about how theranostics is transforming the way we diagnose and treat cancer.
But what exactly is theranostics and why is it such a big deal for patients?
What Is Theranostics? (Simple Explanation)
Theranostics combines therapy and diagnostics into one powerful, personalized approach to care. Instead of treating cancer with a one-size-fits-all method, theranostics allows physicians to:
Identify cancer at the molecular level.
Target it precisely using specialized treatments.
Monitor how the treatment is working in real time.
This “see it and treat it” approach is a major shift in oncology. Rather than relying only on traditional imaging or broad treatments, theranostics focuses on precision medicine tailored to each patient’s disease.
How Theranostics Works
At its core, theranostics uses small radioactive compounds, called radiopharmaceuticals, that bind to specific markers on cancer cells.
Here’s how the process works:
A diagnostic scan is performed to locate cancer cells.
The same target is then used to deliver therapy directly to those cells.
Physicians can track how the cancer responds over time.
This targeted approach allows for more accurate diagnosis and more effective treatment, often with fewer side effects compared to traditional therapies.
Why Theranostics Matters for Patients
Theranostics is not just a scientific advancement, it’s a patient-centered breakthrough.
For many individuals, especially those with complex or advanced cancers, this approach offers:
More precise treatment targeting.
Potential for fewer side effects.
Improved ability to monitor response to therapy.
New options when traditional treatments are limited.
In fact, theranostics is already being used in cancers like prostate cancer and neuroendocrine tumors, with ongoing research expanding its reach even further.
A Growing Field with a Powerful Future
Theranostics continues to gain momentum across the world. Advances in nuclear medicine and molecular imaging are opening the door to more personalized, more effective cancer care.
Emerging therapies using advanced radioisotopes, like actinium-225, are currently being studied in clinical trials and may redefine how we treat difficult cancers in the near future.
World Theranostics Day is not just about celebrating progress, it’s about recognizing what’s coming next.
Watch: Understanding Theranostics in Action
To better understand how theranostics works and why it matters, here are two patient-friendly videos that break it down:
What Is Theranostics? A Simple Explanation
How Targeted Radiopharmaceutical Therapy Works
These resources provide a clear, visual explanation of how theranostics is helping physicians “find and treat” cancer with unprecedented precision.
CB Oncology’s Commitment to Innovation
At CB Oncology, we believe that staying at the forefront of innovation is essential to delivering the best care possible.
That means:
Referring selected patients to clinical trials in theranostics. Dr. Castaneda serves as principal investigator in a number of these trials
Educating patients about emerging treatments like theranostics.
Monitoring clinical advancements and new therapies
Supporting access to cutting-edge care when appropriate.
Providing compassionate, personalized oncology services.
As theranostics continues to evolve, our goal is to ensure our patients understand their options and feel empowered in their care journey.
Looking Ahead: The Next 10 Years of Cancer Care
One of the questions raised during World Theranostics Day is powerful:
What breakthroughs will we be celebrating in 10 years?
If current progress continues, the future may include:
Earlier detection of cancer at the molecular level.
More targeted and less invasive treatments.
Expanded use of theranostics across multiple cancer types.
Improved survival rates and quality of life for patients.
The future of oncology is becoming more precise, more personalized, and more hopeful.
Take the Next Step
If you or a loved one has questions about advanced cancer treatments, imaging, or emerging therapies like theranostics, our team is here to help.
At CB Oncology, Dr. Serguei Castaneda specializes in advanced radiation oncology approaches, including theranostics and targeted radiopharmaceutical therapies, helping guide patients through some of the most innovative treatment options available today.
Contact CB Oncology today to learn more about your options and how we can support your care.